O. Greengard et al., The anti-influenza virus ahent 4-GU-DANA (Zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA, J VIROLOGY, 74(23), 2000, pp. 11108-11114
4-GU-DANA (zanamivir) (as well as DANA and 4-AM-DANA) was found to inhibit
the neuraminidase activity of human parainfluenza virus type 3 (HPF3). The
viral neuraminidase activity is attributable to hemagglutinin-neuraminidase
(HN), an envelope protein essential for viral attachment and for fusion me
diated by the other envelope protein, F. While there is no evidence that HN
's neuraminidase activity is essential for receptor binding and syncytium f
ormation, we found that 4-GU-DANA prevented hemadsorption and fusion of per
sistently infected cells with uninfected cells. In plaque assays, 4-GU-DANA
reduced the number (but not the area) of plaques if present only during th
e adsorption period and reduced plaque area (but not number) if added only
after the 90-min adsorption period. 4-GU-DANA also reduced the area of plaq
ues formed by a neuraminidase-deficient variant, confirming that its interf
erence with cell-cell fusion is unrelated to inhibition of neuraminidase ac
tivity. The order-of-magnitude lower 50% inhibitory concentrations of 4-GU-
DANA (and also DANA and 4-AM-DANA) for plaque area reduction and for inhibi
tion in the fusion assay than for reducing plaque number or blocking hemads
orption indicate the particular efficacy of these sialic acid analogs in in
terfering with cell-cell fusion. In cell lines expressing influenza virus h
emagglutinin (RA) as the only viral protein, we found that 4-GU-DANA had no
effect on hemadsorption but did inhibit HA2b-red blood cell fusion, as jud
ged by both lipid mixing and content mixing. Thus, 4-GU-DANA can interfere
with both influenza virus- and HPF3-mediated fusion. The results indicate t
hat (i) in HPF3, 4-GU-DANA and its analogs have an affinity not only for th
e neuraminidase active site of HN but also for sites important for receptor
binding and cell fusion and (ii) sialic acid-based inhibitors of influenza
virus neuraminidase can also exert a direct, negative effect on the fusoge
nic function of the other envelope protein, HA.